Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Molecular Neurobiology|September 25, 2017
SVCT2 Expression and Function in Reactive Astrocytes Is a Common Event in Different Brain PathologiesKatterine Salazar, Fernando Martínez, Margarita Pérez-Martín, et al.Developmental Cell|March 29, 2017
miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNSHaibo Wang, Ana Lis Moyano, Zhangyan Ma, et al.Scientific Reports|August 22, 2018
α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathiesHazem Abdelkarim, Michael S Marshall, Giuseppe Scesa, et al.Cell Communication and Signaling : CCS|December 22, 2025
Impaired docking and recycling of synaptic vesicles in inherited lysosomal sphingolipidosesDiego Zelada, Natalia Saldivia, Ashna Konjeti, et al.The Journal of Pathology|January 14, 2014
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe diseaseBenjamin R Smith, Marta B Santos, Michael S Marshall, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 14, 2018
microRNA-219 Reduces Viral Load and Pathologic Changes in Theiler's Virus-Induced Demyelinating DiseaseAna Lis Moyano, Jeffrey Steplowski, Haibo Wang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2021
Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe diseaseGregory J Heller, Michael S Marshall, Yazan Issa, et al.Neuron|May 7, 2020
Macrophages Expressing GALC Improve Peripheral Krabbe Disease by a Mechanism Independent of Cross-CorrectionNadav I Weinstock, Daesung Shin, Narayan Dhimal, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 14, 2018
Long-Term Improvement of Neurological Signs and Metabolic Dysfunction in a Mouse Model of Krabbe's Disease after Global Gene TherapyMichael S Marshall, Yazan Issa, Benas Jakubauskas, et al.Journal of Medicinal Chemistry|March 17, 2020
Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase InhibitorsSimona Di Martino, Piero Tardia, Vincenzo Cilibrasi, et al.Pageof 8